Diagnosing and Treating Community-Acquired Pneumonia-A Double-Blind Study?
作者信息
Keynan Yoav, Lother Sylvain A, Laupland Kevin, Rueda Zulma V
机构信息
Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, Canada.
出版信息
J Assoc Med Microbiol Infect Dis Can. 2025 Jun 27;10(2):97-100. doi: 10.3138/jammi-2025-0226. eCollection 2025 Jun.
Abstract
摘要
相似文献
1
Diagnosing and Treating Community-Acquired Pneumonia-A Double-Blind Study?诊断和治疗社区获得性肺炎——一项双盲研究？
J Assoc Med Microbiol Infect Dis Can. 2025 Jun 27;10(2):97-100. doi: 10.3138/jammi-2025-0226. eCollection 2025 Jun.
2
Real-world efficacy and safety of cefepime for pediatric community-acquired pneumonia: a propensity score-matched study.头孢吡肟用于儿童社区获得性肺炎的真实世界疗效和安全性：一项倾向评分匹配研究。
Front Cell Infect Microbiol. 2025 Jun 18;15:1616184. doi: 10.3389/fcimb.2025.1616184. eCollection 2025.
3
Immunomodulatory therapies in community-acquired pneumonia: a protocol for a systematic review and network meta-analysis.社区获得性肺炎的免疫调节治疗：一项系统评价和网状Meta分析方案
BMJ Open. 2025 Jul 10;15(7):e098994. doi: 10.1136/bmjopen-2025-098994.
4
Systematic review on the etiology and antibiotic treatment of pneumonia in human immunodeficiency virus-infected children.系统评价人类免疫缺陷病毒感染儿童肺炎的病因和抗生素治疗。
Pediatr Infect Dis J. 2011 Oct;30(10):e192-202. doi: 10.1097/INF.0b013e31822d989c.
5
Prevalence and Etiology of Community- and Hospital-Acquired Pneumonia in Saudi Arabia and Their Antimicrobial Susceptibility Patterns: A Systematic Review.沙特阿拉伯社区获得性肺炎和医院获得性肺炎的患病率及其抗菌药物敏感性模式：系统评价。
Medicina (Kaunas). 2023 Apr 13;59(4):760. doi: 10.3390/medicina59040760.
6
Vitamin C for preventing and treating pneumonia.维生素C用于预防和治疗肺炎。
Cochrane Database Syst Rev. 2013 Aug 8(8):CD005532. doi: 10.1002/14651858.CD005532.pub3.
7
Systematic review and meta-analysis of the accuracy of lung ultrasound and chest radiography in diagnosing community acquired pneumonia in children.系统评价和荟萃分析肺超声和胸部 X 线摄影在诊断儿童社区获得性肺炎中的准确性。
Pediatr Pulmonol. 2024 Dec;59(12):3130-3147. doi: 10.1002/ppul.27221. Epub 2024 Sep 6.
8
Antibiotics for treating community-acquired pneumonia in people with sickle cell disease.用于治疗镰状细胞病患者社区获得性肺炎的抗生素。
Cochrane Database Syst Rev. 2016 Nov 14;11(11):CD005598. doi: 10.1002/14651858.CD005598.pub4.
9
Insights into the diagnostic and prognostic value of paraoxonase 1-related variables and inflammatory markers in community-acquired pneumonia.对血清对氧磷酶1相关变量和炎症标志物在社区获得性肺炎中的诊断和预后价值的见解。
Chem Biol Interact. 2025 Sep 5;418:111606. doi: 10.1016/j.cbi.2025.111606. Epub 2025 Jun 12.
10
Long-term impacts of Legionnaires' disease on health and wellbeing: rationale, study design and baseline findings of a matched cohort study (LongLEGIO).军团病对健康和福祉的长期影响：配对队列研究（LongLEGIO）的基本原理、研究设计和基线结果
Swiss Med Wkly. 2025 Jun 17;155:4333. doi: 10.57187/s.4333.
本文引用的文献
1
Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021.全球、区域和国家非 COVID-19 下呼吸道感染及病因的发病率、死亡率负担，1990-2021 年：来自 2021 年全球疾病负担研究的系统分析。
Lancet Infect Dis. 2024 Sep;24(9):974-1002. doi: 10.1016/S1473-3099(24)00176-2. Epub 2024 Apr 15.
2
Inflammatory Patterns Associated with in HIV and Pneumonia Coinfections.与HIV和肺炎合并感染相关的炎症模式。
Pathogens. 2024 Feb 14;13(2):173. doi: 10.3390/pathogens13020173.
3
Real-life Assessment of BioFire FilmArray Pneumonia Panel in Adults Hospitalized With Respiratory Illness.成人呼吸道疾病住院患者中生物梅里埃 FilmArray 肺炎Panel 的真实生活评估。
J Infect Dis. 2024 Jan 12;229(1):214-222. doi: 10.1093/infdis/jiad221.
4
The host response in different aetiologies of community-acquired pneumonia.社区获得性肺炎不同病因中的宿主反应。
EBioMedicine. 2022 Jul;81:104082. doi: 10.1016/j.ebiom.2022.104082. Epub 2022 Jun 1.
5
Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients.瑞德西韦早期治疗可降低门诊患者重症 COVID-19 进展风险
N Engl J Med. 2022 Jan 27;386(4):305-315. doi: 10.1056/NEJMoa2116846. Epub 2021 Dec 22.
6
Viral Endothelial Dysfunction: A Unifying Mechanism for COVID-19.病毒引起的血管内皮功能障碍：COVID-19 的统一发病机制
Mayo Clin Proc. 2021 Dec;96(12):3099-3108. doi: 10.1016/j.mayocp.2021.06.027. Epub 2021 Aug 19.
7
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.新冠肺炎危重症患者的肝素治疗性抗凝。
N Engl J Med. 2021 Aug 26;385(9):777-789. doi: 10.1056/NEJMoa2103417. Epub 2021 Aug 4.
8
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.COVID-19 重症患者的白细胞介素 6 受体拮抗剂。
N Engl J Med. 2021 Apr 22;384(16):1491-1502. doi: 10.1056/NEJMoa2100433. Epub 2021 Feb 25.
9
JAK-inhibitor and type I interferon ability to produce favorable clinical outcomes in COVID-19 patients: a systematic review and meta-analysis.JAK 抑制剂和 I 型干扰素在 COVID-19 患者中产生良好临床结局的能力：系统评价和荟萃分析。
BMC Infect Dis. 2021 Jan 11;21(1):47. doi: 10.1186/s12879-020-05730-z.
10
Etiology of community-acquired pneumonia in adults: a systematic review.成人社区获得性肺炎的病因：一项系统评价
Pneumonia (Nathan). 2020 Oct 5;12:11. doi: 10.1186/s41479-020-00074-3. eCollection 2020.
Zotero 插件